| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Viktorija Cernisova, Ngoc Lu-Nguyen, Jessica Trundle, Shan Herath, Alberto Malerba, Linda Popplewel. Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy. International journal of molecular sciences. vol 24. issue 9. 2023-05-14. PMID:37175881. |
duchenne muscular dystrophy (dmd) is a rare neuromuscular disease affecting 1:5000 newborn males. |
2023-05-14 |
2023-08-14 |
mouse |
| Wooi Fang Lim, Carlo Rinald. RNA Transcript Diversity in Neuromuscular Research. Journal of neuromuscular diseases. 2023-05-14. PMID:37182892. |
it is therefore not surprising that splicing mis-regulation is causally associated with a myriad of neuromuscular diseases, including but not limited to amyotrophic lateral sclerosis (als), spinal muscular atrophy (sma), duchenne muscular dystrophy (dmd), and myotonic dystrophy type 1 and 2 (dm1, dm2). |
2023-05-14 |
2023-08-14 |
human |
| Andrew I Mikhail, Sean Y Ng, Stephanie R Mattina, Vladimir Ljubici. AMPK is mitochondrial medicine for neuromuscular disorders. Trends in molecular medicine. 2023-04-20. PMID:37080889. |
here, we survey mitochondrial stresses that are common between, as well as unique to, dmd, dm1, and sma, and which may serve as potential therapeutic targets to mitigate neuromuscular disease. |
2023-04-20 |
2023-08-14 |
Not clear |
| Rachele Rossi, Camilla Johansson, Wendy Heywood, Heloise Vinette, Gabriella Jensen, Hanna Tegel, Albert Jiménez-Requena, Silvia Torelli, Cristina Al-Khalili Szigyarto, Alessandra Ferlin. A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring. International journal of molecular sciences. vol 24. issue 6. 2023-03-29. PMID:36982290. |
duchenne muscular dystrophy (dmd) is a rare neuromuscular disease caused by pathogenic variations in the |
2023-03-29 |
2023-08-14 |
human |
| Peter Harley, Amaia Paredes-Redondo, Gianluca Grenci, Virgile Viasnoff, Yung-Yao Lin, Ivo Liebera. 3D Compartmentalised Human Pluripotent Stem Cell-derived Neuromuscular Co-cultures. Bio-protocol. vol 13. issue 5. 2023-03-13. PMID:36908638. |
human neuromuscular diseases represent a diverse group of disorders with unmet clinical need, ranging from muscular dystrophies, such as duchenne muscular dystrophy (dmd), to neurodegenerative disorders, such as amyotrophic lateral sclerosis (als). |
2023-03-13 |
2023-08-14 |
human |
| Yu Song, Hua-Yan Xu, Ke Xu, Ying-Kun Guo, Lin-Jun Xie, Fei Peng, Rong Xu, Hang Fu, Wei-Feng Yuan, Zi-Qi Zhou, Bo-Chao Cheng, Chuan Fu, Hui Zhou, Xiao-Tang Cai, Xue-Sheng L. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function. Pediatric radiology. 2023-03-09. PMID:36892624. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease characterised by progressive muscular weakness and atrophy. |
2023-03-09 |
2023-08-14 |
Not clear |
| Carolina Migliorelli, Meritxell Gómez-Martinez, Paula Subías-Beltrán, Mireia Claramunt-Molet, Sebastian Idelsohn-Zielonka, Eudald Mas-Hurtado, Felip Miralles, Marisol Montolio, Marina Roselló-Ruano, Julita Medina-Cantill. Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy. Sensors (Basel, Switzerland). vol 23. issue 2. 2023-01-21. PMID:36679627. |
(1) background: duchenne (dmd) is a rare neuromuscular disease that progressively weakens muscles, which severely impairs gait capacity. |
2023-01-21 |
2023-08-14 |
Not clear |
| Christopher R Heier, Nikki M McCormack, Christopher B Tully, James S Novak, Breanne L Newell-Stamper, Alan J Russell, Alyson A Fiorill. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47. Journal of cachexia, sarcopenia and muscle. 2023-01-11. PMID:36628607. |
becker muscular dystrophy (bmd) is a genetic neuromuscular disease of growing importance caused by in-frame, partial loss-of-function mutations in the dystrophin (dmd) gene. |
2023-01-11 |
2023-08-14 |
mouse |
| Bruno Lamanna, Marina Vinciguerra, Miriam Dellino, Gabriele Cascella, Gerardo Cazzato, Enrica Macorano, Antonio Malvasi, Salvatore Scacco, Ettore Cicinelli, Vera Loizzi, Antonella Vimercati, Gennaro Cormio, Francesco Paduano, Eliano Cascardi, Marco Tatull. Turner Syndrome Mosaicism 45,X/46,XY with Genital Ambiguity and Duchenne Muscular Dystrophy: Translational Approach of a Rare Italian Case. International journal of molecular sciences. vol 23. issue 22. 2022-11-26. PMID:36430887. |
duchenne muscular dystrophy (dmd) is an inherited neuromuscular disease with an x-linked recessive pattern of inheritance that predominantly affects males, while females are usually asymptomatic. |
2022-11-26 |
2023-08-14 |
Not clear |
| Siyi Gan, Shulei Liu, Haiyan Yang, Liwen W. Clinical and genetic characteristics of Chinese Duchenne/Becker muscular dystrophy patients with small mutations. Frontiers in neuroscience. vol 16. 2022-11-24. PMID:36419457. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are amongst the inherited neuromuscular diseases with the highest incidence. |
2022-11-24 |
2023-08-14 |
Not clear |
| Christine Péladeau, Bernard J Jasmi. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy. Methods in molecular biology (Clifton, N.J.). vol 2587. 2022-11-18. PMID:36401046. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease caused by mutations and deletions within the dmd gene, which result in a lack of dystrophin protein at the sarcolemma of skeletal muscle fibers. |
2022-11-18 |
2023-08-14 |
mouse |
| Robert Gutierrez, Allison McCrady, Chelsea Masterson, Sarah Tolman, Mehdi Boukhechba, Laura Barnes, Silvia Blemker, Rebecca Schar. Upper Extremity Examination for Neuromuscular Diseases (U-EXTEND): Protocol for a Multimodal Feasibility Study. JMIR research protocols. vol 11. issue 10. 2022-10-27. PMID:36301603. |
neuromuscular diseases, such as spinal muscular atrophy (sma) and duchenne muscular dystrophy (dmd), may result in the loss of motor movements, respiratory failure, and early mortality in young children and in adulthood. |
2022-10-27 |
2023-08-14 |
Not clear |
| Guofang Chen, Tingyi Wei, Hui Yang, Guoling Li, Haisen L. CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives. Cells. vol 11. issue 19. 2022-10-14. PMID:36230926. |
duchenne muscular dystrophy (dmd) is a severe neuromuscular disease arising from loss-of-function mutations in the |
2022-10-14 |
2023-08-14 |
Not clear |
| Li Gan, Leslie C L Wu, Jenna A Wood, Monica Yao, Chris M Treleaven, Nelsa L Estrella, Bruce M Wentworth, Gunnar J Hanson, Marco A Passin. A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in Molecular therapy. Nucleic acids. vol 30. 2022-10-03. PMID:36189424. |
a cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in antisense rna technology is a strategy for the treatment of duchenne muscular dystrophy (dmd), a progressive and universally fatal x-linked neuromuscular disease caused by frameshift mutations in the gene encoding dystrophin. |
2022-10-03 |
2023-08-14 |
Not clear |
| Zahraa Hassan Shehata, Hoda Rabea, Rasha El Sherif, Mohamed E Abdelrahim, Dalia M Dawou. Estimating Societal Cost of Illness and Patients' Quality of Life of Duchenne Muscular Dystrophy in Egypt. Value in health regional issues. vol 33. 2022-09-26. PMID:36162195. |
duchenne muscular dystrophy (dmd) is a rare neuromuscular disease that causes substantial economic burden. |
2022-09-26 |
2023-08-14 |
Not clear |
| Alexandra Monceau, Dylan Moutachi, Mégane Lemaitre, Luis Garcia, Capucine Trollet, Denis Furling, Arnaud Klein, Arnaud Ferr. Dystrophin restoration after AAV-U7-mediated dmd exon-skipping is modulated by muscular exercise in the severe D2-mdx DMD murine model. The American journal of pathology. 2022-09-16. PMID:36113555. |
duchenne muscular dystrophy (dmd) is a severe neuromuscular disease caused by dmd mutations resulting in the absence of dystrophin in skeletal muscle, with a greater susceptibility to damage during contraction (exercise). |
2022-09-16 |
2023-08-14 |
mouse |
| Yu Zhang, Hui Li, Takahiko Nishiyama, John R McAnally, Efrain Sanchez-Ortiz, Jian Huang, Pradeep P A Mammen, Rhonda Bassel-Duby, Eric N Olso. A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing. Molecular therapy. Nucleic acids. vol 29. 2022-08-29. PMID:36035749. |
duchenne muscular dystrophy (dmd) is a lethal neuromuscular disease caused by mutations in the x-linked dystrophin ( |
2022-08-29 |
2023-08-14 |
mouse |
| Vittoria Marini, Fabiola Marino, Flaminia Aliberti, Nefele Giarratana, Enrico Pozzo, Robin Duelen, Álvaro Cortés Calabuig, Rita La Rovere, Tim Vervliet, Daniele Torella, Geert Bultynck, Maurilio Sampaolesi, Yoke Chin Cha. Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression. Frontiers in cell and developmental biology. vol 10. 2022-08-29. PMID:36035984. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular disease which to date is incurable. |
2022-08-29 |
2023-08-14 |
human |
| Amédée Mollard, Cécile Peccate, Anne Forand, Julie Chassagne, Laura Julien, Pierre Meunier, Zoheir Guesmia, Thibaut Marais, Marc Bitoun, France Piétri-Rouxel, Sofia Benkhelifa-Ziyyat, Stéphanie Lorai. Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription. Scientific reports. vol 12. issue 1. 2022-06-11. PMID:35690627. |
duchenne muscular dystrophy is a severe neuromuscular disease causing a progressive muscle wasting due to mutations in the dmd gene that lead to the absence of dystrophin protein. |
2022-06-11 |
2023-08-14 |
mouse |
| Doreen Z Mhandire, David P Burns, Angela L Roger, Ken D O'Halloran, Mai K ElMalla. Breathing in Duchenne muscular dystrophy: Translation to therapy. The Journal of physiology. 2022-05-27. PMID:35620971. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular disease caused by a deficiency in dystrophin - a structural protein which stabilizes muscle during contraction. |
2022-05-27 |
2023-08-13 |
Not clear |